Purchases and Sales Made in Q4 2022 in Pasithea Therapeutics Corp. (KTTA)
This table provides information about the institutional ownership of Pasithea Therapeutics Corp. (KTTA) during Q4 2022. The information is specifically focused on institutions that hold shares of Pasithea Therapeutics Corp..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
30.9KNew |
$17K - $804K
|
30.9K
$165K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
9.39K+ 165.93% |
$5.16K - $244K
|
15K
$80.4K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
7.28K+ 133.53% |
$4K - $189K
|
12.7K
$68K
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
5KNew |
$2.75K - $130K
|
5K
$26.7K
|
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
2K+ 200.0% |
$1.1K - $52K
|
3K
$16K
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
351+ 0.22% |
$193 - $9.13K
|
160K
$855K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
33New |
$18.2 - $858
|
33
$176
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 3.6% |
$2.2 - $104
|
115
$614
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-351- 0.36% |
$193 - $9.13K
|
98.2K
$525K
|
|
|
Feb 10, 2023
Q4 2022
|
K2 Principal Fund, L.P.
Toronto, A6 |
SELL
|
- |
-209K- 42.57% |
$115K - $5.44M
|
282K
$1.51M
|